MAGS, MRNA, CEDC, - CRWESelect.com Stock News! Magal Security Systems Ltd., Marina Biotech Inc., Central European Distribution Corp. (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) November 29, 2011 -- To view video, and read the full article visit URL http://crweselect.com/27553/stock-alerts/mags-mrna-cedc-crweselectcom-stock-news-magal-security-systems-ltd-marina-biotech-inc-central-european-distribution-corp-video-included-inside/

Magal Security Systems Ltd. (NASDAQ:MAGS)

MAGS announced today its financial results for the three month period ended September 30, 2011 . Revenues for the third quarter of 2011 increased 107% to a record $27.7 million . This is compared with $13.4 million , of revenues in the third quarter of 2010. Net income in the quarter was $7.1 million . This is compared with a net loss of $799,000 in the third quarter of 2010.

MAGS is a leading international provider of security, safety and site management solutions and products.

For more information MAGS please visit http://www.magal-ssl.com

****

Marina Biotech, Inc. (NASDAQ:MRNA)

MRNA announced today that the Marina/Debiopharm Research and Development (R&D) Team has selected and confirmed the lead DiLA2 formulation for a RNAi-based therapy for the treatment of non-muscle invasive bladder cancer. The team has also advanced the lead UsiRNA candidates towards in vivo evaluation to identify a candidate drug product for continued development. The joint R&D Team expects to select the lead candidate in early 2012. Including lead candidate selection, the Company anticipates achieving several near-term research milestones in the first half of 2012.

MRNA is a biotechnology company focused on the development and commercialization of oligonucleotide-based therapeutics utilizing multiple mechanisms of action including RNA interference (RNAi) and messenger RNA translational blocking. The Marina Biotech pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs -- in bladder cancer and malignant ascites. Marina Biotech entered into an exclusive agreement with Debiopharm SA for the development and commercialization of the bladder cancer program. Marina Biotech's goal is to improve human health through the development of RNAi- and oligonucleotide-based compounds and drug delivery technologies that together provide superior therapeutic options for patients.

For more information MRNA please visit http://www.marinabio.com

****

Central European Distribution Corp. (NASDAQ:CEDC)

According to reports, Vodka producer Russian Standard Vodka, owned by billionaire Roustam Tariko, has bought a 9.9 percent stake in Central European Distribution Corporation - symbol CEDC

CEDC, together with its subsidiaries, produces, imports, and distributes alcoholic beverages in Poland, Hungary, and the Russian Federation. It produces and sells vodka under the Absolwent, Zubrowka, Bols, Palace, Soplica, Green Mark, Parliament, Zhuravli, and Royal brands.

For more information CEDC please visit http://www.cedc.com

To read the full article visit URL http://crweselect.com/27553/stock-alerts/mags-mrna-cedc-crweselectcom-stock-news-magal-security-systems-ltd-marina-biotech-inc-central-european-distribution-corp-video-included-inside/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

MAGScrweselect1129
MRNAcrweselect1129
CEDCcrweselect1129

CEDC     Central European Distribution     Magal Security Systems     MAGS     Marina Biotech     mrna     NASDAQ CEDC     select